Presentation given at the USAID SQALE Symposium, Bridging the Quality Gap - Strengthening Quality Improvement in Community Health Services, by Charles Mito on behalf of MEASURE Evaluation PIMA. http://usaidsqale.reachoutconsortium.org/
This presentation was given by Miriam Taegtmeyer at a meeting of the Overseas Development Institute on the 20 January 2016. In it she discusses the REACHOUT quality improvement approach.
This is the Plenary Presentation of CheyLeaphy Heng, Program Team Manager, Rainbow Community Kampuchea (RoCK) on the plenary topic: "UPR as an advocacy strategy for SOGIE-SC issues in Cambodia". This presentation was part of the 14th session of #APCRSHR10 Virtual, on the theme of "Sexual orientation and gender identity and SRHR in Asia Pacific".
Chair: Dr Chivorn Var, Convener of APCRSHR10 and Executive Director of Reproductive Health Association of Cambodia (RHAC)
Plenary Speaker: CheyLeaphy Heng, Program Team Manager, Rainbow Community Kampuchea (RoCK) | "UPR as an advocacy strategy for SOGIE-SC issues in Cambodia"
ABSTRACT PRESENTERS:
* Saroj Tamang | Male-to-Female Transgender Community barrier and challenges in access of Sexual Health Services
* Saritha P Viswan | A review of transgender issues in India
* Sobo Malik | Limited Access to Health Rights Resulting in Increase Self Medication
* Ciptasari Prabhawanti | Sexual Identity, Sexual Orientation, Sexual Risk and Condom Use Behaviors of Clients of Transgender Sex Workers in Jakarta, Indonesia
For further information, visit www.bit.ly/apcrshr10virtual14
Conference website: www.apcrshr10cambodia.org or check out www.bit.ly/apcrshr10virtual
Thanks
Presentation given at the USAID SQALE Symposium, Bridging the Quality Gap - Strengthening Quality Improvement in Community Health Services, by Charles Mito on behalf of MEASURE Evaluation PIMA. http://usaidsqale.reachoutconsortium.org/
This presentation was given by Miriam Taegtmeyer at a meeting of the Overseas Development Institute on the 20 January 2016. In it she discusses the REACHOUT quality improvement approach.
This is the Plenary Presentation of CheyLeaphy Heng, Program Team Manager, Rainbow Community Kampuchea (RoCK) on the plenary topic: "UPR as an advocacy strategy for SOGIE-SC issues in Cambodia". This presentation was part of the 14th session of #APCRSHR10 Virtual, on the theme of "Sexual orientation and gender identity and SRHR in Asia Pacific".
Chair: Dr Chivorn Var, Convener of APCRSHR10 and Executive Director of Reproductive Health Association of Cambodia (RHAC)
Plenary Speaker: CheyLeaphy Heng, Program Team Manager, Rainbow Community Kampuchea (RoCK) | "UPR as an advocacy strategy for SOGIE-SC issues in Cambodia"
ABSTRACT PRESENTERS:
* Saroj Tamang | Male-to-Female Transgender Community barrier and challenges in access of Sexual Health Services
* Saritha P Viswan | A review of transgender issues in India
* Sobo Malik | Limited Access to Health Rights Resulting in Increase Self Medication
* Ciptasari Prabhawanti | Sexual Identity, Sexual Orientation, Sexual Risk and Condom Use Behaviors of Clients of Transgender Sex Workers in Jakarta, Indonesia
For further information, visit www.bit.ly/apcrshr10virtual14
Conference website: www.apcrshr10cambodia.org or check out www.bit.ly/apcrshr10virtual
Thanks
Jennifer Mason, Senior Advisor for FP/HIV Integration for USAID's Office of Population and Reproductive Health describes the agency's approach to integrating family planning services with HIV health services and provides country examples of integration practices.
Jennifer Mason, Senior Advisor for FP/HIV Integration for USAID's Office of Population and Reproductive Health describes the agency's approach to integrating family planning services with HIV health services and provides country examples of integration practices.
As members of the body of Christ, what is our role in fostering collaboration to increase patient access and higher quality care? Barbara Campbell, RPh, CCN, Executive Director, ReLink Global Health-The Dalton Foundation explores the experiences of establishing the Haiti Health Network, a collaboration of more than 500 healthcare providers.
The Association for the Development of Pakistan (ADP) is a volunteer-driven, engaged venture philanthropy organization that works with promising nonprofits and funds carefully selected development projects across Pakistan.
This is our first board presentation and YTD update that we want to share with all our stakeholders.
http://developpakistan.org
This is the abstract presentation of Dr Harjyot Khosa, which was made as part of the 12th session of 10th Asia Pacific Conference on Reproductive and Sexual Health and Rights (#APCRSHR10) Virtual. This session was held in lead up to #WorldAIDSDay and #16DaysofActivism against sexual and other forms of gender-based violence, on the theme of "HIV/AIDS and sexual and reproductive health and rights (SRHR) in Asia and the Pacific".
Chair: Jennifer Butler, Director, UNFPA Pacific Sub Regional office based in Fiji
Plenary Speaker: Eamonn Murphy, Regional Director, UNAIDS, Asia and the Pacific | “Solidarity and Accountability: HIV, SRHR and the COVID response”
Abstract Presenters:
-------------------------
* Jude Tayaben | Successes, Pitfalls, and Moving Forward: Adivayan Youth Health Center- A school-based program addressing Adolescent Sexuality, and Reproductive Health Issues in Benguet, Philippines
* Samreen, Manisha Dhakal | Integrating transgender health into HIV and SRHR programming in Indonesia, Nepal, Thailand and Vietnam
* Harjyot Khosa | Stigma, sex work and non-disclosure to health care providers: Exploring dynamics of anal sex through community led monitoring to bridge gaps in HIV care continuum services
* Angela Kelly Hanku, Agnes K. Mek | I can, I want, I will and Young & Positive: Two visual method projects with young women living with HIV in Papua New Guinea
For more information on the session, please visit
www.bit.ly/apcrshr10virtual12
Official conference website: www.apcrshr10cambodia.org
Thanks
Quality improvement and Community Health Worker performance: A mixed method r...REACHOUTCONSORTIUMSLIDES
A presentation that describes the REACHOUT approach to studying close-to-community providers with quality improvement interventions designed to improve the performance of programmes.
This inaugural NYeC | PCIP Learning Series is targeted at DSRIP PPS leads, service providers, and others who would like to learn more about New York State’s current and future programs to increase HIT adoption, usage, and practice transformation.
In this first session, we will focus on two tactical areas. First, how DSRIP PPS leaders can analyze participating provider data to facilitate project planning, outreach, and program success. Second, an industry expert from Primary Care Development Corp will provide a helpful overview of how organizations can prepare for and achieve Patient Centered Medical Home (PCMH) recognition.
There will be more sessions to follow and we welcome your input to help shape future content to assist those working to transform healthcare in New York State.
Agenda:
• 9:00 am - Welcome, Programs Update (REC, EP2, NYS PTN)
• 9:10 am - DSRIP – PPS Provider Analysis Reporting and Outreach
• 9:30 am - PCMH – Overview and Readiness
• 9:50 am - Q&A, Call for future subjects
May 14, 2015
Working Toward Eradication (Hepatitis C/HIV Coinfection Presentation) - Alex ...Office of HIV Planning
At the October 2016 meeting of the Philadelphia Ryan White Part A Planning Council, Alex Shirreffs of the Philadelphia Department of Public Health discussed an ongoing project to improve the care continuum for HIV/HCV co-infected people of color.
Pius Tih Muffih, PhD, MPH, Director of the Cameroon Baptist Convention Health Services (CBCHS) presents how CBCHS partners with other local groups to bring services to prevent mother-to-child prevention of HIV in Cameroon at the CCIH 2018 Annual Conference.
Presented by Dr. Nelson Gitonga, Insight Health Advisor, Kenya during Regional AIDS Training Network (RATN) 12th General Council Meeting held in Mombasa, Kenya from 24th - 29th June 2013
Presented by Jonathan Gunthorp of SAT Regional, South Africa, during Regional AIDS Training Network (RATN) 12th General Council Meeting held in Mombasa, Kenya from 24th - 29th June 2013
Presented by Dr. Mungule Chikoye, during Regional AIDS Training Network, RATN 12th General Council Meeting held in Mombasa, Kenya from 24th - 29th June 2013
Organizational development and systems strengthening of community based organizations through targeted capacity building to enhance the HIV and AIDS response in Eastern Kenya
Engaging the Wives of State Governors in supporting the response to the needs of women living with HIV within the framework of Positive Health, Dignity & Prevention
Strengthening the monitoring and evaluation capacity of civil society organization to improve the reach and quality of OVC care and support services: Experiences from Lesotho
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
1. Transitioning an internationally
managed HIV program to local
ownership: the experience of EGPAF
-Tanzania
John Stephen, BVM, MSc & MBA
Associate Director, Field Programs – EGPAF
HIV Capacity Summit, Birchwood
Hotel
1
19 Mar 2013
2. Presentation outline
• Introduction
• Why transition to local affiliate
• Phases of transition process
• Establishment of a local affiliate
• Criteria for selection of the region
• Program implementation
• Capacity building initiatives
• Evidence for achievements
• Challenges and counter strategies
• Lessons learnt
• Conclusions
3. 1.0 Introduction
• Local ownership of HIV service delivery and HSS
programs in sub-Saharan Africa is critical to
ensure long-term sustainability.
• In 2004, EGPAF received Track One funding from
CDC to implement Project HEART.
• Transition was mandated as part of the Track 1.0
re-authorization by the US Congress in 2008.
• EGPAF believes in country ownership.
• Transition is the EGPAF’s process of transferring
existing programs and services to local partners.
4. 2.0 Why transition to local affiliates ?
• Promote local capacity and sustainability of
programs.
• Accountability through affiliation agreement.
• Monitoring of quality through regular accreditation
system.
• Capacity building and transfer of EGPAF systems.
• Guided by principles and standards for affiliation.
• Shared elements (logo, mission) facilitate the
development of a strongly linked global network
and synergy.
• Promotes common purpose and shared strategy
to achieve mission.
6. 4.0 Ariel Glaser Pediatric AIDS
Healthcare Initiative (AGPAHI)
• Non profit and autonomous organisation organized
locally at both the grassroots and national levels.
• Registered on 21 Feb 2011 as local NGO under
NGO Act No 24 of 2002 of Tanzania and launched
on 18 May 2011.
• Vision: envisions a world where children and
families have access to quality health services and
live free from HIV/AIDS to realize their full
potential.
7. 5.0 Establishment of AGPAHI
• A founding committee of six members formed.
• Stakeholders involvement.
• Drafted paperwork for registration of the new
NGO.
• Ten BoD candidates screened through the
developed criteria, eight members selected.
• Procedures and policies developed.
• AGPAHI official inauguration on 18 May 2011.
• Affiliation agreement btn EGPAF & AGPAHI
signed.
•
8. 6.0 Criteria for selection of Shinyanga
• High HIV prevalence - high 7.4%.
• Underserviced HIV program – potential for
programmatic expansion.
• Strong leadership and local government support.
• Potential for donor to support expansion of the
program.
• Less number of NGOs/CSOs working on HIV
programs.
10. 7.0 Program implementation
• EGPAF transitioned one of six regions; 41 HIV
C&T clinics with 20,272 patients.
• AGPAHI adopted EGPAF’s implementation
model.
• AGPAHI received a C&T sub award from EGPAF
• AGPAHI received direct funding from CDC.
• Annual accreditation review.
• In January 2012 AGPAHI received a sub award
from EGPAF on PMTCT/ RCH.
• July 2012, AGPAHI received a USAID funding on
“Innovations in family planning, reproductive
11. 8.0 Capacity building initiatives for
AGPAHI
• Secondment of EGPAF staff to AGPAHI.
• Policies and procedures (fin, M&E,CGIS, HR).
• Board members orientation workshop.
• AGPAHI staff trained and administered tools;
OCVAT, SCP & CCA in Shinyanga.
• Accreditation review in Sept 2011, Jun & Sept
2012
• Technical / operations support from EGPAF.
• Bilateral management training – Aug 2011.
• Effective Leadership and Gov training in Oct 2011.
• AGPAHI participated in NBD workshop in 2012.
• Quarterly DAW and sub grantee monitoring
13. 10.0 Evidence for achievements
• A full fledged independent local NGO.
• Four funding sources within two years.
• HIV Care and Treatment clinics expanded from 41
to 68 with over 61,546 patients.
• Program expanded to new regions of Geita &
Simiyu within two years.
• Good support and collaboration with Government.
• Integration of HIV and family planning programs.
14. 11.0 Challenges and counter strategies
• Narrow funding base for AGPAHI, mostly USG and
lack of unrestricted funds. Strategy – prospecting
for non USG donors.
• Supply chain management challenges - test kits.
Strategy – sourcing for local suppliers.
• Higher services demands with limited resources.
Strategy – integration for HIV services.
• Stigmatization of local NGOs in Tanzania. Strategy
– evidence good work by results.
• Transition lacked clarity, appropriate guidance and
donors keep changing their focus. Strategy –
EGPAF and AGPAHI worked on best practices.
15. 12.0 Lessons learnt
• Establishing an organization as an affiliate shortens
the turn round processes for the organization to
take off smoothly.
• Affiliation enables local NGOs access funds within
short time.
• Choice of board members is critical to success.
13.0 Conclusions
• Establishment of AGPAHI as a local partner is step
toward ensuring sustain of HIV programs in Tz.
• Affiliation helps to leverage financial, programmatic
and technical resources.